professor888 personal page - To The Moon

professor888

professor888

No personal profile

46Follow

25Followers

0Topic

0Badge

2023-03-25

$Assembly Biosciences Inc.(ASMB)$ Prioritization of core inhibitor candidate ABI-4334 and pausing of core inhibitor candidate ABI-H3733 based on data to date from ongoing clinical Phase 1 studies of both candidates and chronic toxicology observation for ABI-H3733Phase 1a complete clinical data for all ABI-4334 dose cohorts expected in April 2023Advancing expanded research portfolio, with additional development candidate nomination anticipated in 2023 and IND/CTA submission for herpesvirus candidate ABI-5366 planned for the first half of 2024SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeting serious

2023-03-06

Assembly Biosciences (ASMB) Gets a Buy from Mizuho Securities

2023-03-06

Mizuho Securities analyst maintained a Buy rating on Assembly Biosciences ( – ) today and set a price target of $3.00. The company’s shares opened today at $1.53.Syed covers the Healthcare sector, focusing on stocks such as Cytokinetics, Biogen, and Coherus Biosciences. According to , Syed has an average return of -10.9% and a 43.14% success rate on recommended stocks.Assembly Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $2.75.The company has a one-year high of $2.42 and a one-year low of $0.82. Currently, Assembly Biosciences has an average volume of 321.9K.TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which are most likely to make moves following th

2021-04-29

$Assembly Biosciences Inc.(ASMB)$?16.08 ⚠️

2020-10-26

…

China to Sanction Boeing, Lockheed Martin, Raytheon Over Taiwan

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3544001019280972","uuid":"3544001019280972","gmtCreate":1580906996990,"gmtModify":1706620735915,"name":"professor888","pinyin":"professor888","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":25,"headSize":46,"tweetSize":204,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":4,"name":"文化虎","nameTw":"文化虎","represent":"学有所成","factor":"发布30条非转发主帖,其中3条优质帖","iconColor":"8867FB","bgColor":"BDC5FF"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.06%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.09","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.85%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":659318363,"gmtCreate":1679673620157,"gmtModify":1679676342932,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASMB\">$Assembly Biosciences Inc.(ASMB)$&nbsp;</a>Prioritization of core inhibitor candidate ABI-4334 and pausing of core inhibitor candidate ABI-H3733 based on data to date from ongoing clinical Phase 1 studies of both candidates and chronic toxicology observation for ABI-H3733Phase 1a complete clinical data for all ABI-4334 dose cohorts expected in April 2023Advancing expanded research portfolio, with additional development candidate nomination anticipated in 2023 and IND/CTA submission for herpesvirus candidate ABI-5366 planned for the first half of 2024SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeting serious","listText":"<a href=\"https://laohu8.com/S/ASMB\">$Assembly Biosciences Inc.(ASMB)$&nbsp;</a>Prioritization of core inhibitor candidate ABI-4334 and pausing of core inhibitor candidate ABI-H3733 based on data to date from ongoing clinical Phase 1 studies of both candidates and chronic toxicology observation for ABI-H3733Phase 1a complete clinical data for all ABI-4334 dose cohorts expected in April 2023Advancing expanded research portfolio, with additional development candidate nomination anticipated in 2023 and IND/CTA submission for herpesvirus candidate ABI-5366 planned for the first half of 2024SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeting serious","text":"$Assembly Biosciences Inc.(ASMB)$ Prioritization of core inhibitor candidate ABI-4334 and pausing of core inhibitor candidate ABI-H3733 based on data to date from ongoing clinical Phase 1 studies of both candidates and chronic toxicology observation for ABI-H3733Phase 1a complete clinical data for all ABI-4334 dose cohorts expected in April 2023Advancing expanded research portfolio, with additional development candidate nomination anticipated in 2023 and IND/CTA submission for herpesvirus candidate ABI-5366 planned for the first half of 2024SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeting serious","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/659318363","isVote":1,"tweetType":1,"viewCount":633,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"9000000000000339","authorId":"9000000000000339","name":"vippy","avatar":"https://static.tigerbbs.com/c0126a7d8aadf37410e3ec43acf556ad","crmLevel":1,"crmLevelSwitch":0,"idStr":"9000000000000339","authorIdStr":"9000000000000339"},"content":"I hope it drops like this, until, at least, $9.00.","text":"I hope it drops like this, until, at least, $9.00.","html":"I hope it drops like this, until, at least, $9.00."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":627131109,"gmtCreate":1678101097503,"gmtModify":1678101097503,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"Assembly Biosciences (ASMB) Gets a Buy from Mizuho Securities","listText":"Assembly Biosciences (ASMB) Gets a Buy from Mizuho Securities","text":"Assembly Biosciences (ASMB) Gets a Buy from Mizuho Securities","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/627131109","isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":627133449,"gmtCreate":1678100974683,"gmtModify":1678100974683,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"Mizuho Securities analyst maintained a Buy rating on Assembly Biosciences ( – ) today and set a price target of $3.00. The company’s shares opened today at $1.53.Syed covers the Healthcare sector, focusing on stocks such as Cytokinetics, Biogen, and Coherus Biosciences. According to , Syed has an average return of -10.9% and a 43.14% success rate on recommended stocks.Assembly Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $2.75.The company has a one-year high of $2.42 and a one-year low of $0.82. Currently, Assembly Biosciences has an average volume of 321.9K.TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which are most likely to make moves following th","listText":"Mizuho Securities analyst maintained a Buy rating on Assembly Biosciences ( – ) today and set a price target of $3.00. The company’s shares opened today at $1.53.Syed covers the Healthcare sector, focusing on stocks such as Cytokinetics, Biogen, and Coherus Biosciences. According to , Syed has an average return of -10.9% and a 43.14% success rate on recommended stocks.Assembly Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $2.75.The company has a one-year high of $2.42 and a one-year low of $0.82. Currently, Assembly Biosciences has an average volume of 321.9K.TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which are most likely to make moves following th","text":"Mizuho Securities analyst maintained a Buy rating on Assembly Biosciences ( – ) today and set a price target of $3.00. The company’s shares opened today at $1.53.Syed covers the Healthcare sector, focusing on stocks such as Cytokinetics, Biogen, and Coherus Biosciences. According to , Syed has an average return of -10.9% and a 43.14% success rate on recommended stocks.Assembly Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $2.75.The company has a one-year high of $2.42 and a one-year low of $0.82. Currently, Assembly Biosciences has an average volume of 321.9K.TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which are most likely to make moves following th","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":31,"commentSize":24,"repostSize":0,"link":"https://ttm.financial/post/627133449","isVote":1,"tweetType":1,"viewCount":903,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109847351,"gmtCreate":1619686011173,"gmtModify":1704727996484,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASMB\">$Assembly Biosciences Inc.(ASMB)$</a>?16.08 &nbsp;⚠️","listText":"<a href=\"https://laohu8.com/S/ASMB\">$Assembly Biosciences Inc.(ASMB)$</a>?16.08 &nbsp;⚠️","text":"$Assembly Biosciences Inc.(ASMB)$?16.08 ⚠️","images":[{"img":"https://static.tigerbbs.com/f1ad492f276dccbdad417199b46d2d33","width":"760","height":"760"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109847351","isVote":1,"tweetType":1,"viewCount":432,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":301550548,"gmtCreate":1603701665784,"gmtModify":1705072938343,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"…","listText":"…","text":"…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/301550548","repostId":"2078757355","repostType":2,"repost":{"id":"2078757355","pubTimestamp":1603697685,"share":"https://ttm.financial/m/news/2078757355?lang=&edition=fundamental","pubTime":"2020-10-26 15:34","market":"us","language":"en","title":"China to Sanction Boeing, Lockheed Martin, Raytheon Over Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2078757355","media":"Bloomberg","summary":"(Bloomberg) -- China will impose unspecified sanctions on defense contractors Lockheed Martin Corp.,","content":"<html><body><p>(Bloomberg) -- China will impose unspecified sanctions on defense contractors Lockheed Martin Corp., a unit of Boeing Co. and Raytheon Technologies Corp. after the U.S. approved an arms sale to Taiwan last week, Chinese Foreign Ministry spokesman Zhao Lijian said Monday. </p>\n<p>“In order to uphold national interests we decide to take necessary measures, and we will impose sanctions on U.S. entities,” Zhao said at a press briefing in Beijing. He mentioned “Boeing Defense” would be among those sanctioned. </p>\n<p>The State Department last week approved $1.8 billion in new arms for Taiwan and submitted the package to Congress for a final review.</p>\n<p>State Department Approves $1.8 Billion in Weapons for Taiwan (4)</p>\n<p>In July, China had announced sanctions on Lockheed Martin for a previous arms sale to Taiwan. </p>\n<p>For more articles like this, please visit us at bloomberg.com</p>\n<p>Subscribe now to stay ahead with the most trusted business news source.</p>\n<p>©2020 Bloomberg L.P.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China to Sanction Boeing, Lockheed Martin, Raytheon Over Taiwan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina to Sanction Boeing, Lockheed Martin, Raytheon Over Taiwan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-10-26 15:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/china-sanction-boeing-lockheed-martin-073445071.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- China will impose unspecified sanctions on defense contractors Lockheed Martin Corp., a unit of Boeing Co. and Raytheon Technologies Corp. after the U.S. approved an arms sale to Taiwan...</p>\n\n<a href=\"https://finance.yahoo.com/news/china-sanction-boeing-lockheed-martin-073445071.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RTX":"雷神技术公司","BA":"波音","LMT":"洛克希德马丁"},"source_url":"https://finance.yahoo.com/news/china-sanction-boeing-lockheed-martin-073445071.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2078757355","content_text":"(Bloomberg) -- China will impose unspecified sanctions on defense contractors Lockheed Martin Corp., a unit of Boeing Co. and Raytheon Technologies Corp. after the U.S. approved an arms sale to Taiwan last week, Chinese Foreign Ministry spokesman Zhao Lijian said Monday. \n“In order to uphold national interests we decide to take necessary measures, and we will impose sanctions on U.S. entities,” Zhao said at a press briefing in Beijing. He mentioned “Boeing Defense” would be among those sanctioned. \nThe State Department last week approved $1.8 billion in new arms for Taiwan and submitted the package to Congress for a final review.\nState Department Approves $1.8 Billion in Weapons for Taiwan (4)\nIn July, China had announced sanctions on Lockheed Martin for a previous arms sale to Taiwan. \nFor more articles like this, please visit us at bloomberg.com\nSubscribe now to stay ahead with the most trusted business news source.\n©2020 Bloomberg L.P.","news_type":1},"isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":627133449,"gmtCreate":1678100974683,"gmtModify":1678100974683,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"Mizuho Securities analyst maintained a Buy rating on Assembly Biosciences ( – ) today and set a price target of $3.00. The company’s shares opened today at $1.53.Syed covers the Healthcare sector, focusing on stocks such as Cytokinetics, Biogen, and Coherus Biosciences. According to , Syed has an average return of -10.9% and a 43.14% success rate on recommended stocks.Assembly Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $2.75.The company has a one-year high of $2.42 and a one-year low of $0.82. Currently, Assembly Biosciences has an average volume of 321.9K.TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which are most likely to make moves following th","listText":"Mizuho Securities analyst maintained a Buy rating on Assembly Biosciences ( – ) today and set a price target of $3.00. The company’s shares opened today at $1.53.Syed covers the Healthcare sector, focusing on stocks such as Cytokinetics, Biogen, and Coherus Biosciences. According to , Syed has an average return of -10.9% and a 43.14% success rate on recommended stocks.Assembly Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $2.75.The company has a one-year high of $2.42 and a one-year low of $0.82. Currently, Assembly Biosciences has an average volume of 321.9K.TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which are most likely to make moves following th","text":"Mizuho Securities analyst maintained a Buy rating on Assembly Biosciences ( – ) today and set a price target of $3.00. The company’s shares opened today at $1.53.Syed covers the Healthcare sector, focusing on stocks such as Cytokinetics, Biogen, and Coherus Biosciences. According to , Syed has an average return of -10.9% and a 43.14% success rate on recommended stocks.Assembly Biosciences has an analyst consensus of Moderate Buy, with a price target consensus of $2.75.The company has a one-year high of $2.42 and a one-year low of $0.82. Currently, Assembly Biosciences has an average volume of 321.9K.TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which are most likely to make moves following th","images":[],"top":1,"highlighted":2,"essential":1,"paper":1,"likeSize":31,"commentSize":24,"repostSize":0,"link":"https://ttm.financial/post/627133449","isVote":1,"tweetType":1,"viewCount":903,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":659318363,"gmtCreate":1679673620157,"gmtModify":1679676342932,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASMB\">$Assembly Biosciences Inc.(ASMB)$&nbsp;</a>Prioritization of core inhibitor candidate ABI-4334 and pausing of core inhibitor candidate ABI-H3733 based on data to date from ongoing clinical Phase 1 studies of both candidates and chronic toxicology observation for ABI-H3733Phase 1a complete clinical data for all ABI-4334 dose cohorts expected in April 2023Advancing expanded research portfolio, with additional development candidate nomination anticipated in 2023 and IND/CTA submission for herpesvirus candidate ABI-5366 planned for the first half of 2024SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeting serious","listText":"<a href=\"https://laohu8.com/S/ASMB\">$Assembly Biosciences Inc.(ASMB)$&nbsp;</a>Prioritization of core inhibitor candidate ABI-4334 and pausing of core inhibitor candidate ABI-H3733 based on data to date from ongoing clinical Phase 1 studies of both candidates and chronic toxicology observation for ABI-H3733Phase 1a complete clinical data for all ABI-4334 dose cohorts expected in April 2023Advancing expanded research portfolio, with additional development candidate nomination anticipated in 2023 and IND/CTA submission for herpesvirus candidate ABI-5366 planned for the first half of 2024SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeting serious","text":"$Assembly Biosciences Inc.(ASMB)$ Prioritization of core inhibitor candidate ABI-4334 and pausing of core inhibitor candidate ABI-H3733 based on data to date from ongoing clinical Phase 1 studies of both candidates and chronic toxicology observation for ABI-H3733Phase 1a complete clinical data for all ABI-4334 dose cohorts expected in April 2023Advancing expanded research portfolio, with additional development candidate nomination anticipated in 2023 and IND/CTA submission for herpesvirus candidate ABI-5366 planned for the first half of 2024SOUTH SAN FRANCISCO, Calif., March 22, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative antiviral therapeutics targeting serious","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/659318363","isVote":1,"tweetType":1,"viewCount":633,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"9000000000000339","authorId":"9000000000000339","name":"vippy","avatar":"https://static.tigerbbs.com/c0126a7d8aadf37410e3ec43acf556ad","crmLevel":1,"crmLevelSwitch":0,"idStr":"9000000000000339","authorIdStr":"9000000000000339"},"content":"I hope it drops like this, until, at least, $9.00.","text":"I hope it drops like this, until, at least, $9.00.","html":"I hope it drops like this, until, at least, $9.00."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":109847351,"gmtCreate":1619686011173,"gmtModify":1704727996484,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASMB\">$Assembly Biosciences Inc.(ASMB)$</a>?16.08 &nbsp;⚠️","listText":"<a href=\"https://laohu8.com/S/ASMB\">$Assembly Biosciences Inc.(ASMB)$</a>?16.08 &nbsp;⚠️","text":"$Assembly Biosciences Inc.(ASMB)$?16.08 ⚠️","images":[{"img":"https://static.tigerbbs.com/f1ad492f276dccbdad417199b46d2d33","width":"760","height":"760"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/109847351","isVote":1,"tweetType":1,"viewCount":432,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":627131109,"gmtCreate":1678101097503,"gmtModify":1678101097503,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"Assembly Biosciences (ASMB) Gets a Buy from Mizuho Securities","listText":"Assembly Biosciences (ASMB) Gets a Buy from Mizuho Securities","text":"Assembly Biosciences (ASMB) Gets a Buy from Mizuho Securities","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/627131109","isVote":1,"tweetType":1,"viewCount":234,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":301550548,"gmtCreate":1603701665784,"gmtModify":1705072938343,"author":{"id":"3544001019280972","authorId":"3544001019280972","name":"professor888","avatar":"https://static.tigerbbs.com/108043556e4daf976cba0852147c0296","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3544001019280972","authorIdStr":"3544001019280972"},"themes":[],"htmlText":"…","listText":"…","text":"…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/301550548","repostId":"2078757355","repostType":2,"repost":{"id":"2078757355","pubTimestamp":1603697685,"share":"https://ttm.financial/m/news/2078757355?lang=&edition=fundamental","pubTime":"2020-10-26 15:34","market":"us","language":"en","title":"China to Sanction Boeing, Lockheed Martin, Raytheon Over Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2078757355","media":"Bloomberg","summary":"(Bloomberg) -- China will impose unspecified sanctions on defense contractors Lockheed Martin Corp.,","content":"<html><body><p>(Bloomberg) -- China will impose unspecified sanctions on defense contractors Lockheed Martin Corp., a unit of Boeing Co. and Raytheon Technologies Corp. after the U.S. approved an arms sale to Taiwan last week, Chinese Foreign Ministry spokesman Zhao Lijian said Monday. </p>\n<p>“In order to uphold national interests we decide to take necessary measures, and we will impose sanctions on U.S. entities,” Zhao said at a press briefing in Beijing. He mentioned “Boeing Defense” would be among those sanctioned. </p>\n<p>The State Department last week approved $1.8 billion in new arms for Taiwan and submitted the package to Congress for a final review.</p>\n<p>State Department Approves $1.8 Billion in Weapons for Taiwan (4)</p>\n<p>In July, China had announced sanctions on Lockheed Martin for a previous arms sale to Taiwan. </p>\n<p>For more articles like this, please visit us at bloomberg.com</p>\n<p>Subscribe now to stay ahead with the most trusted business news source.</p>\n<p>©2020 Bloomberg L.P.</p></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China to Sanction Boeing, Lockheed Martin, Raytheon Over Taiwan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina to Sanction Boeing, Lockheed Martin, Raytheon Over Taiwan\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-10-26 15:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/china-sanction-boeing-lockheed-martin-073445071.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- China will impose unspecified sanctions on defense contractors Lockheed Martin Corp., a unit of Boeing Co. and Raytheon Technologies Corp. after the U.S. approved an arms sale to Taiwan...</p>\n\n<a href=\"https://finance.yahoo.com/news/china-sanction-boeing-lockheed-martin-073445071.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RTX":"雷神技术公司","BA":"波音","LMT":"洛克希德马丁"},"source_url":"https://finance.yahoo.com/news/china-sanction-boeing-lockheed-martin-073445071.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2078757355","content_text":"(Bloomberg) -- China will impose unspecified sanctions on defense contractors Lockheed Martin Corp., a unit of Boeing Co. and Raytheon Technologies Corp. after the U.S. approved an arms sale to Taiwan last week, Chinese Foreign Ministry spokesman Zhao Lijian said Monday. \n“In order to uphold national interests we decide to take necessary measures, and we will impose sanctions on U.S. entities,” Zhao said at a press briefing in Beijing. He mentioned “Boeing Defense” would be among those sanctioned. \nThe State Department last week approved $1.8 billion in new arms for Taiwan and submitted the package to Congress for a final review.\nState Department Approves $1.8 Billion in Weapons for Taiwan (4)\nIn July, China had announced sanctions on Lockheed Martin for a previous arms sale to Taiwan. \nFor more articles like this, please visit us at bloomberg.com\nSubscribe now to stay ahead with the most trusted business news source.\n©2020 Bloomberg L.P.","news_type":1},"isVote":1,"tweetType":1,"viewCount":404,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}